Pharmaceuticals News and Research

RSS

Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

But on Wednesday in Charlotte, Kay Hagan stood without hesitation next to Janet Colm, chief executive of the Planned Parenthood Action Fund of Central North Carolina, and proudly bashed her opponent, Thom Tillis, for reducing women's rights on abortion and birth control.

17 Oct 2014

Amgen files lawsuit against Regeneron, Sanofi to prevent infringing manufacture of alirocumab

Amgen today announced that it filed a lawsuit in the United States (U.S.) District Court of Delaware against Sanofi, Aventisub LLC, formerly doing business as Aventis Pharmaceuticals Inc. (collectively "Sanofi"), and Regeneron Pharmaceuticals, Inc. ("Regeneron") for patent infringement of U.S. Patent Numbers 8,563,698, 8,829,165, and 8,859,741.

17 Oct 2014

Scientists develop promising vaccination strategy to counteract RSV infection

Respiratory Syncytial Virus causes severe respiratory tract infections and worldwide claims the lives of 160,000 children each year. Scientists at VIB and Ghent University have succeeded in developing a promising vaccination strategy to counteract this common virus infection.

17 Oct 2014

Newly developed agent filters out toxins from body in the event of overdose

Every minute counts in the event of an overdose. ETH professor Jean-Christophe Leroux and his team have developed an agent to filter out toxins from the body more quickly and efficiently.

17 Oct 2014

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today announced a new license agreement aimed at advancing dual-purpose candidate vaccines to protect against rabies and Ebola viruses.

17 Oct 2014

Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

In the nine years Parker has now served on the court, he has made the most of his opportunities. Child custody disputes, for instance, have made good occasions to expound on the role of religion in parental rights.

17 Oct 2014

New oral biologic medication successfully treats precancerous intestinal inflammation

An oral biologic medication has successfully treated chronic, precancerous inflammation in the intestine, according to results of an animal study authored by an MD/PhD student in the University at Buffalo School of Medicine and Biomedical Sciences.

16 Oct 2014

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Kalorama Information believes an experimental vaccine distribution in the United Kingdom and other similar developments point to a growing flu vaccine market, as well as a growing market for the production of these vaccines.

16 Oct 2014

Health Media Network to use SITO's mobile advertising platform to improve healthcare outcomes

SITO Mobile Ltd., a leading mobile media solutions provider, and Health Media Network (HMN), one of the nation's fastest growing digital Point of Care media companies, today announced a partnership by which Health Media Network will leverage SITO Mobile's mobile media platform to power a national location-based advertising network within physician offices nationwide.

16 Oct 2014

Highland completes US$25 million offering of Class A Common Shares

Highland Therapeutics Inc., a pharmaceutical company, today announced it has completed a US$25 million offering of Class A Common Shares. The financing was led by a private equity partner that is committed to Highland's long-term success.

16 Oct 2014

Promising vaccination strategy to counteract RSV

16 Oct 2014

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

To enhance the transparency of clinical trials for new drugs, a number of pharmaceutical firms have begun sharing data with investigators outside their own companies.

16 Oct 2014

Treeway, LACDR join forces to optimize clinical trial designs, data-analysis for ALS

Treeway and LACDR at the University of Leiden join forces and form a collaboration focused on the optimization of clinical trial designs and data-analysis for ALS (Amyotrophic Lateral Sclerosis) through the use of population disease progression models.

16 Oct 2014

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved OFEV (nintedanib) capsules for oral use for the treatment of idiopathic pulmonary fibrosis (IPF).

15 Oct 2014

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.

15 Oct 2014

PhRMA launches new website to educate consumers about ABCs of health coverage

Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) launched Access Better Coverage.org, a new website designed to educate consumers about the ABCs of health coverage and access to prescription medicines.

14 Oct 2014

Imperial researchers plan to test DTP3 drug in multiple myeloma patients

Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.

14 Oct 2014

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Johnson & Johnson today announced sales of $18.5 billion for the third quarter of 2014, an increase of 5.1% as compared to the third quarter of 2013. Operational results increased 5.8% and the negative impact of currency was 0.7%. Domestic sales increased 11.6%. International sales decreased 0.3%, reflecting operational growth of 1.0% and a negative currency impact of 1.3%.

14 Oct 2014

Issues on coverage: Steep Rx costs; federal plan eliminates 'transgender exclusion'

Even patients with insurance are finding that specialty drugs can quickly eat a hole in their wallets because insurers are often putting them in a special tier and demanding high consumer co-payments. Also, the State Department is getting rid of the "transgender exclusion" in it largest health plan, and some consumer advocates are suggesting that people getting coverage on the health marketplaces be allowed to get "wrap-around" plans through their employers.

14 Oct 2014

Ziehm Imaging wins Gold Stevie award at 11th annual International Business Awards

Ziehm Imaging has been awarded with the Gold Stevie Award in the category "New Product & Product Management - Health and Pharmaceuticals" in the 11th annual International Business Awards.

13 Oct 2014

Pharmaceuticals News and Research

Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

Amgen files lawsuit against Regeneron, Sanofi to prevent infringing manufacture of alirocumab

Scientists develop promising vaccination strategy to counteract RSV infection

Newly developed agent filters out toxins from body in the event of overdose

NIAID announces license agreement to develop dual-purpose candidate vaccines for rabies, Ebola

Longer Looks: An Alabama Judge's Dismantling Of Roe V. Wade; The Mystery Of Enterovirus; Mutating Ebola

New oral biologic medication successfully treats precancerous intestinal inflammation

Kalorama Information: Experimental vaccine distribution in the UK points to growing flu vaccine market

Health Media Network to use SITO's mobile advertising platform to improve healthcare outcomes

Highland completes US$25 million offering of Class A Common Shares

Promising vaccination strategy to counteract RSV

Pharmaceutical firms share data to enhance transparency of clinical trials for new drugs

Treeway, LACDR join forces to optimize clinical trial designs, data-analysis for ALS

Boehringer Ingelheim's OFEV (nintedanib) capsules receive FDA approval for IPF treatment

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

PhRMA launches new website to educate consumers about ABCs of health coverage

Imperial researchers plan to test DTP3 drug in multiple myeloma patients

Johnson & Johnson's sales increase 5.1% to $18.5 billion in Q3 2014

Issues on coverage: Steep Rx costs; federal plan eliminates 'transgender exclusion'

Ziehm Imaging wins Gold Stevie award at 11th annual International Business Awards

Event guide: World ADC Asia eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence